Clinical Trials Browser

Phase 2 × OTHER × Unresectable Hepatocellular Carcinoma × Clear all

NCT07351513 2026-01-20

A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Hepatocellular Carcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Unresectable Hepatocellular Carcinoma